Advertisement

Drug Facts | Aspirin

02:37 EDT 20th June 2013 | BioPortfolio
Note: While we endeavour to keep our records up-to-date one should not rely on these details being accurate without first consulting a professional. Click here to read our full medical disclaimer.

Aspirin 325mg

Pain reliever/fever reducer

temporarily relieves

Reye's syndrome:Children and teenagers should not use this medicine for chicken pox or flu symptoms before a doctor is consulted about Reye's syndrome, a rare but serious illness reported to be associated with aspirin.

If you consume 3 or more alcoholic drinks every day, ask your doctor whether you should take aspirin or other pain reliever/fever reducers. Aspirin may cause stomach bleeding.

if you are allergic to aspirin or any other pain reliever/fever reducer

taking a prescription drug for

ask a health professional before use.It is especially important not to use aspirin during the last 3 months of pregnancy unless definitely directed to do so by a doctor because it may cause problems in the unborn child or complications during delivery.

In case of overdose, get medical help or contact a Poison Control Center right away.

dry starch, citric acid, carboxymethyl starch sodium, starch, starch paste

Aspirin

Manufacturer

Kareway Product, Inc.

Active Ingredients

Source

Drugs and Medications [ 435 Associated Drugs and Medications listed on BioPortfolio]

Healthy accents aspirin [DZA Brands LLC]

DZA Brands, LLC Aspirin Drug Facts

Equaline aspirin [Supervalu Inc]

SuperValu Inc. Aspirin Drug Facts

Equaline aspirin [Supervalu Inc]

SuperValu Inc. Chewable Aspirin 81 mg Drug Facts

Sunmark aspirin [McKesson]

McKesson Aspirin Drug Facts

Sunmark aspirin [McKesson]

McKesson Aspirin Drug Facts

Clinical Trials [ 285 Associated Clinical Trials listed on BioPortfolio]

Pharmacokinetic Study Comparing Aspirin and Effervescent Aspirin

To determine the bioequivalence of new formula of aspirin relative to the established commercial effervescent aspirin when taken orally by healthy adult subjects

Pharmacokinetic Study Comparing Aspirin and Aspirin Granules

To determine the bioequivalence of new formula of aspirin relative to the established commercial aspirin plain tablet and aspirin dry granules when taken orally by healthy adult subjects

The Effect of Serum LDL Lowering on Aspirin Resistance

Aspirin resistance is the persistent platelet activation, demonstrated by platelet function tests (1). The hypothesis is that:LDL lowering by statin in patients with aspirin resistance ca...

Aspirin Responsiveness in Women at Risk for Cardiac Events

The objective of this pilot study is to evaluate the prevalence of biological aspirin resistance in women at risk for CHD taking low dose (81 mg) aspirin. Aspirin responsiveness will be m...

Aspirin Resistance in Coronary Artery Disease

The purpose of this study is to evaluate possible mechanisms of aspirin resistance at a molecular level in aspirin-treated patients with coronary artery disease. We hypothesize that certa...

PubMed Articles [ 696 Associated PubMed Articles listed on BioPortfolio]

Can resistance to aspirin be reversed after an additional dose?

Aspirin resistance or aspirin non-responsiveness is a recently described phenomenon which has been consistently associated with an increased risk of cardiovascular events. This study was designed to d...

Aspirin resistance in patients with acute ischemic stroke.

Aspirin is used in ischemic stroke therapy. However, some patients are not responsive to the antithrombotic action of aspirin. The aim of this study was to assess the prevalence of aspirin resistance...

Aspirin for preventing venous thromboembolism.

To the Editor: In their report on the Aspirin to Prevent Recurrent Venous Thromboembolism (ASPIRE) trial, Brighton et al. (Nov. 22 issue)(1) describe a nonsignificant decrease in the rate of recurrent...

Aspirin for preventing venous thromboembolism.

To the Editor: In their report on the Aspirin to Prevent Recurrent Venous Thromboembolism (ASPIRE) trial, Brighton et al. (Nov. 22 issue)(1) describe a nonsignificant decrease in the rate of recurrent...

Aspirin for preventing venous thromboembolism.

To the Editor: In their report on the Aspirin to Prevent Recurrent Venous Thromboembolism (ASPIRE) trial, Brighton et al. (Nov. 22 issue)(1) describe a nonsignificant decrease in the rate of recurrent...

Search BioPortfolio:
Advertisement

Drugs and Medication Quicklinks


Searches Linking to this Drug Record

Advertisement